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DEVELOPMENT OF PROTOTYPE REMOTE SENSING KIT FOR 
SUBCUTANEOUS AND BRAIN GLUCOSE MONITORING 
     
ABSTRACT 
 
 
The study of subcutaneous and brain striatum glucose levels employing 
wireless glucose microsensor was proposed. A new implantable glucose sensor 
has been fabricated by immobilizing glucose oxidase on a chemically – modified 
carbon fiber prior to dipping in rat’s serum for 3 days for preconditioning. The 
sensor was inserted subcutaneously and in the brain striatum on a male 
spraguely rat without any incision. The “preconditioned” microsensor, operated in 
the amperometric mode with an applied potential of 0.23 V vs. Ag|AgCl, was able 
to directly measure the glucose concentration upon infusion of glucose. The 
apparent Michaelis – Menten (Km) value at 5.1 ± 0.5 mM was obtained. The 
“preconditioned” microsensor shows good stability and reproducibility with 
constant response spanned over 25 days. Most common interferences in glucose 
analysis were minimized by the outerlayer Nafion®. The sensitivities of both 
“clean” and “preconditioned” microsensors were 510 µM and 530 µM 
respectively. Analysis of glucose by both wired and wireless techniques are 
comparable with the conventional glucometer kit with R.S.D. value of 1.5%. 
Hematology examinations showed minimal material – tissue interaction.  
The wireless transmission of glucose level was achieved by means of 
Bluetooth technology, embedded in a microprocessor. As the implanted 
microsensor was not affected by biocompatibility failures, these mechanical 
 xvi
devices allowed a more refined understanding towards glucose control in diabetic 
patients. This study has demonstrated that the wireless transmission 
measurement of subcutaneous and brain striatum glucose is feasible. The 
measurements of subcutaneous and brain striatum made via wireless sensing 
showed no significant variation (p > 0.88 two – way ANOVA; n=5), with 
measurements made via conventional method and glucometer kit. This indicated 
a statistically insignificant change in sensitivity.  
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PEMBANGUNAN KIT PENDERIAAN JARAK JAUH PROTOTAIP BAGI 
PEMONITORAN GLUKOSA SUBKUTIN DAN OTAK 
 
     ABSTRAK 
Kajian tentang paras glukosa subkutin and dan otak dengan 
menggunakan mikropenderia glukosa tanpa wayar telah dicadangkan. Alat 
mikropenderia untuk tujuan memantau tahap glukosa didalam subkutin and otak 
telahpun direka dengan mengimobilisasikan enzim glucose oxidase ke atas 
gentian karbon sebelum ia di rendam di dalam serum tikus untuk tujuan pra-
keadaan. Mikropenderia itu dapat dimasukkan ke dalam subkutin and bahagian 
striatum otak tanpa kesukaran. Mikropenderia dioperasi dalam mod 
amperometric dengan keupayaan potential +0.23 V vs Ag/AgCl mampu 
menyukat tahap glukosa dengan mudah. Nilai pemalar Michealis Menten yang 
diperoleh ialah 5.1 ± 0.5 mM. Mikropenderia “prakeadaan” ini adalah amat stabil 
and menunjukkan kebolehulangan yang tinggi dengan gerakbalas yang stabil 
selama 25 hari. Kebanyakan gangguan dalam penentuan glukosa telahpun 
dikurangkan dengan penggunaan lapisan Nafion®. Kepekaan bagi kedua – dua 
mikropenderia ialah 510 µM dan 530 µM. Analisis glukosa dengan menggunakan 
kaedah wayar dan tanpa wayar adalah setanding dengan analisis daripada kit 
glucometer dengan nilai R.S.D. sebanyak 1.5%. Kajian hematologi menunjukkan 
interaksi antara bahan dan tisu adalah amat minimal.  
Penghantaran tahap glukosa tanpa wayar dijalankan dengan 
menggunakan teknologi Bluetooth yang digabungkan dalam suatu 
 xviii
pemikroproses. Oleh kerana mikropenderia itu tidak dijejaskan oleh masalah 
kebioserasian, penggunaan alat mekanikal ini membolehkan kawalan glukosa 
dalam pesakit diabetik dijalankan dengan lebih berkesan. Kajian ini telah 
menunjukkan transmisi tanpa wayar tahap glukosa subkutin dan bahagian 
striatum otak mampu dilakukan. Ukuran glukosa subkutin dan striatum otak 
dengan menggunakan kaedah tanpa wayar tidak menunjukkan variasi bererti (p 
> 0.88 ANOVA dua hala; n=5) dengan pengukuran yang dibuat dengan 
menggunakan alat lazim dan kit glucometer. Ini menunjukkan tiada perubahan 
bererti statistik dari segi kepekaan. 
 
 
 
 1
1.0 INTRODUCTION 
 
1.1 Relation between Blood Glucose Levels and Diabetes Mellitus 
Insulin which is secreted by the islets of Langerhans of the pancreas [1 – 
3], contains four types of cell; (i) B – (or β –) cells secrete insulin (ii), A– cells 
secrete glucagons (iii), D– cells secrete somatostatin and (iv) PP cells secrete 
pancreatic polypeptide (the function of which is unknown). The core of each islet 
contains mainly the predominant B–cells surrounded by a mantle of A– cells 
interspersed with either D– cells or PP cells. The insulin is synthesized as a 
precursor in the rough endoplasmic reticulum and usually, any insulin that is 
active in one species is often active in another. Blood glucose concentration is 
the main factor controlling the synthesis and secretion of insulin. B – cells 
corresponds both to the rate of change of blood glucose and to the absolute 
glucose concentration. There is a steady basal release of insulin and also a 
response to a change in blood glucose. The response to increase in blood 
glucose has two phases; (i) the initial rapid phase reflecting the release of stored 
hormone and (ii) the slower phase, reflecting both continued release of stored 
hormone and new synthesis. Insulin entering the blood circulation greatly 
enhances the uptake of glucose in certain tissues but with only minimal effect on 
the uptake of glucose by brain tissues. Hence, the response to the change in 
blood glucose level becomes abnormal only in diabetes mellitus. 
Diabetes mellitus is a complex endocrine metabolic disorder that resulted 
from a total or partial lack of insulin. The earliest manifestation of the disease is 
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the loss control of the blood glucose level. There are three different major groups 
of diabetes i.e., gestational, non – insulin dependant (maturity – onset diabetes) 
and insulin dependant diabetes (juvenile – onset diabetes). In all, diabetes 
mellitus occurs upon absolute deficiency of insulin, which is secreted 
continuously by pancreatic beta cells. The secretion of insulin in response to 
glucose is rapid and could be triggered even by as low as 2 mM glucose [1]. The 
secretion is stopped when insulin has brought the glucose level to its basal. This 
overall mechanism keeps the blood glucose level in check. Thus, the destruction 
of pancreatic beta cells could lead to severe insulin deficiency. Hyperglycemia is 
a classic symptom of diabetes mellitus but hyperglycemic condition without other 
classic symptoms is not dispositive of a diagnosis of diabetes mellitus. 
Hyperglycaemia is due to uncontrolled hepatic glucose output and reduce uptake 
of glucose by skeletal muscle with reduce glycogen synthesis. However, 
hyperglycemia is also an independent medical condition with other causes [2]. As 
the renal threshold for glucose re-absorption is exceeded, glucose spills over into 
the urinary tract. Hence, for this very reason, it is important to monitor the 
glucose level in human blood. 
 
1.2 Glucose Transport to the Brain 
1.2.1 The blood – brain barrier  
Over 100 years ago, a simple experimental showed that if blue dye was 
injected into the blood stream of an animal, that tissues of the whole body except 
the brain and spinal cord could turn blue. These bizarre observations i.e. the 
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failure of the brain and spinal cord to be stained at autopsy was observed by 
Ehrlich et al [3 – 6]. To explain this, a barrier, namely the blood – brain barrier 
(BBB), was thought to exist between the blood vessels and the brain and this 
barrier prevented materials from entering the brain. The structure of the BBB 
remains elusive until recent reports [7 – 9] have shown that the BBB consisted of 
microvascular endothelial cells held together by tight junctions. These endothelial 
cells were somehow different from other endothelial cells due to the absence of 
fenestrations and the endothelial cells were linked by tight junctions. These tight 
junctions prevented molecular communication between the brain or the central 
nervous system (CNS) and the plasma (Figure 1). Only certain hydrophilic 
molecules such as monoamines, glucose, acetylcholine and L – amino acids 
diffused across the BBB while small lipophilic molecules, i.e. O2 and CO2, 
penetrated the barrier freely [10 – 12]. Such a rigid separation imposes at least 
two or more critical conditions;  
1) Cells of the immune system had minimal access to the BBB. The CNS 
was thought to be excluded from the activities in the immune system and  
2) Important therapeutically active compounds had limited access to the 
brain as well. Only a fraction of the neuroactive drugs penetrate the BBB 
and was mediated by a transporter, which can act either to facilitate entry 
into the brain or to diminish it by pumping the compound from the 
endothelial cell interior back into the bloodstream. Drugs that gain entry in 
this way includes various sedative histamine antagonists and those were 
excluded are such as antibacterial and anticancer drugs that are substrate  
 4
 
 
 
 
Figure 1: The microvascular structure of the blood – brain barrier. 
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for the P – glycoprotein transporter [8]. The fully differentiated BBB consists of a 
complex cellular system of highly specialized endothelial cells, a number of 
pericytes embedded in the basal membrane perivascular macrophages and 
astrocytic endfeet. 
While the endothelial cells form the forefront of the BBB, the interaction with 
adjacent cells seems to be a prerequisite for barrier function. Among the features 
of BBB properties were; 
1) Tight junctions are domains of occluded intracellular clefts which formed 
intramembrane of strands and appeared as a chain of fusion points [13 – 16]. 
Unlike simple tight junctions, these junctions in BBB provide high electrical 
resistance and low permeability in concert with a stable morphology  
2) The endothelial cells have lower rate of transcytosis in comparison to other 
peripheral organs and minimal transcellular exchange of solutes and  
3) The intake of important molecules into the CNS system was mediated by 
specific transport and carrier molecules. This mediated diffusion was energy 
free, as in the case of mediating glucose into the brain. These three features 
allowed cerebral microcapillaries to form a tight cellular layer with a high 
transendothelial electrical resistance (TEER) [17 – 22]. 
 
1.2.2 Blood – brain barrier glucose transport 
The brain uses glucose, largely through oxidative metabolism, as its 
primary fuel for energy generation. When blood glucose levels are reduced i.e. 
insulin administration to levels below 3 mmol/L, subtle brain dysfunction occurs in 
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humans within minutes. There is little short-term flexibility of the brain for 
facultative use of alternative fuels. Normally, the brain depends upon a 
continuous supply of glucose from the blood stream. Glucose must be 
transported into the brain through the endothelial cells of the brain 
microvasculature using facilitated diffusion by transport carrier proteins.  
Glucose transport is one of the most essential and most studied of the 
BBB transport systems. Tight junctions of the BBB endothelia block solutes, 
including blood-borne glucose, from crossing between cells into brain 
extracellular space. Glucose, as a polar, hydrophilic compound, does not 
sufficiently diffuse either into or out of the intact monolayer of the endothelial cells 
(ECs) lining brain capillaries. To maintain the brain’s high rate of aerobic 
metabolism and neuronal homeostasis, highly regulated transport of glucose 
must occur through regionally selective, facilitated transport [23, 24]. In response 
to this high demand, glucose is transported rapidly via transporter proteins. There 
are saturable and unsaturable components to the transport. Saturable transport 
occurs via an energy-independent hexose transporter across the two sides of the 
cell membrane, while diffusion process occur intra- and paracellularly. Different 
members of the family of hexose transporters, GLUTs, are found in the brain and 
throughout the mammalian system [25]. One member, GLUT1, is located on the 
BBB endothelium, both luminally and abluminally [25]. The 55-kDa GLUT1 
isoform, also found in human erythrocytes, has been credited as the main 
glucose transporter of the BBB endothelia. 
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1.3 Electrochemical microsensors fabrication 
Analytical, biological and clinical chemists have for decades concerned 
themselves with the development of instruments and techniques capable of 
determining the identity and concentration of chemical substances that affect 
living things. Recently, this endeavor has focused on electrochemical biosensors, 
small portable or disposable sensing devices that can be used to detect 
biologically important subtances in vivo or in vitro.   
Electrochemical amperometric microsensors have become powerful tools 
for studying fundamental chemical signaling in the body fluid [26 – 31]. The 
measurement is done by maintaining potential at a constant level sufficient for 
reduction/oxidation of the species of interest (or a substance electrochemically 
coupled to it). The current that flows is then proportional to the analyte 
concentration. In comparison with other analytical techniques, such microsensors 
possessed simplicity of operation and substrate selectivity of the enzymes. In 
addition to reducing tissue damage, miniaturization of the cathode area made the 
microsensor less sensitive to convection. This is important if the microsensor 
were to be implanted in the brain tissues. When the brain tissues were examined 
under light microscope after microsensor – based measurements, they bore no 
evidence that the microsensor has been implanted before. In other words, the 
“damage track” that the microelectrode left behind was too small [28]. One of the 
approaches to monitor the glucose concentration in human blood is by means of 
a mechanical device i.e. glucose sensor. The availability of implantable glucose 
sensors, first introduced during the early 80s, has improved the monitoring 
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process [30]. The measurement is possible because of a high transfer rate of 
glucose from blood vessels to the interstitial space which results in a short lag 
time between changes of the blood glucose concentration and the subcutaneous 
tissue. It has also been reported [31, 32] that the subcutaneous glucose 
concentration is at the same level as blood glucose under certain conditions. 
Therefore, any glucose sensor for in vivo application would have to be rapid in its 
response. Several enzyme – based glucose sensors [26 – 28, 30 - 33] have been 
applied for the in vivo or subcutaneous glucose monitoring with some degree of 
success (Table 1). As noted, most of these sensors are too large to be suitable 
for in vivo monitoring if frequent changes of the sensor are required. For such 
applications, a miniaturized sensor (less than 0.1mm in diameter) is needed that 
can be conveniently implanted by the patient. A sensor with an outer diameter of 
less than 0.1mm will be acceptable considering that the needles used for their 
daily insulin injections are in 0.3mm range. The fabrication of such devices 
usually requires the deposition of several layers of polymer and enzyme directly 
to the sensor. The miniaturization of the sensor, therefore, is not trivial. In 
addition, these sensors, upon implantation have relatively short “implantable life”. 
The decrease in response over time is, probably, due to an inflammatory reaction 
which occurs at the electrode – solution interface. The material tissue interaction 
upon sensor implantation is the biggest obstacle in developing a viable 
implantable sensor. Biocompability failures, i.e. fibrous encapsulation and 
membrane biodegradation limited the sensor’s longevity and caused 
inflammatory skin reaction at the implantation site. 
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Table 1: Glucose sensors used for subcutaneous glucose monitoring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shape o.d., (mm) Determinant site in vivo shelf life 
Needle type 1.0 H2O2 5 days 
Needle type 2.5 H2O2 8 days 
Needle type 1.3 Dimethylferrocene 10 days 
Needle type 0.5 Dimethylferrocene 14 days 
Needle type 0.35 H2O2 14 days 
planar 1.0 (width) H2O2 14 days 
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The application of these glucose microsensors normally requires electrical 
communication between the active centre of the enzyme and the electrode 
surface [32 – 35]. Two buried redox active centers, flavin adenine dinucleotide 
(FAD), are found in 1 unit of glucose oxidase (GOx). These FAD centers are 
oxidized by O2 which diffuses through the insulating protein shell. The overall 
enzymatic process could be illustrated as in the following equation, 
 
GOxox  +  glucose  →  GOxred  +  gluconolactone   (1) 
GOxred  +  O2  →  GOxox  +  H2O2      (2) 
 
From equations (1) and (2), the amount of glucose can be determined by 
detection of either H2O2 or O2. However, both of these approaches have caused 
analytical difficulties as O2 concentration usually fluctuates in the 
microenvironment of the brain. Thus, redox mediators have been added to 
shuttle the electron from FAD centers and electrode surfaces. In such systems, 
equation 2 is replaced by the following, 
 GOxred  +  MEDox  →  GOxox  +  MEDred  +  H+    (3) 
 MEDred  →  MEDox  +  e-       (4) 
In this process, the mediator completes the redox cycle. The electrooxidization of 
the MED is utilized in the analytical detection of glucose.  
 Even though the use of chemicals as mediator(s) improved electron 
transfer, they are always costly. Sometimes they are not very sensitive at very 
low analyte concentration, and their compability with the enzyme concerned is 
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also questionable. Hence, the need to design biosensors which do not use 
mediators i.e. mediatorless. In recent years, various conducting polymers were 
employed in the fabrication of mediatorless sensors. One such polymer whch is 
extensively studied is poly – 4 vinylpyridine (P4VP) whose solution and 
metallocomplexes have been used in the preparation of chemically modified 
electrodes [34, 37, 39]. Isolation and purification of these complexes are normally 
complicated, expensive and time consuming. The P4VP layer so produced also 
tend to dissociate if an inert is not used together with low ionic strength solution 
[34, 37]. The direct polymerization of P4VP onto carbon paste electrodes for the 
detection of glucose has been reported [39]. However, the paste in such 
electrodes is difficult to reproduce, leading to irreproducible sensors. In addition 
to this, the immobilized enzyme, usually, suffers premature denaturation around 
the highly lipophilic environment of the paste. Thus, carbon fibre was chosen as it 
is typically carbon with acceptable conductivity and minimal cost [35]. 
 
1.4 In vitro glucose sensors: blood glucose test strips 
 Blood glucose test strips (Figure 2) rely on the coimmobilization of GOx 
and dimethylferrocene on a screen printed carbon surface [36 – 44]. The 
ferrocene in oxidized form acts as an artificial electron acceptor that shuttles 
electrons between the enzyme and carbon surface. The following reaction 
sequence occurs; 
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• Enzymatic reaction: glucose diffusing towards the electrode is oxidized to 
gluconic acid by the enzyme immobilized in a suitable matrix on the 
electrode surface 
Glucose + GOxred → gluconolactone + GOxox   (5) 
 
• Mediator reaction: the oxidized form of the enzyme is regenerated by 
oxidation by the ferricinium ion, which thus acts as a cofactor for the 
enzyme 
GOxox + 2FeCp2+ → GOxred + 2FeCp2 + 2H+   (6) 
 
• Amperometric reaction: ferrocene is electrochemically oxidized at the 
electrode surface at the electrode surface with a reversible E1/2 at +165mV 
versus SCE 
2FeCp2 → 2FeCp2+ + 2H+     (7) 
 
Equation 5 is kinetically controlled and governed by the diffusion of substrate 
towards and through the immobilized enzyme layer where glucose is gradually 
consumed by oxidation of the enzyme. Equation 6 is virtually assumed to be 
quantitative. Equation 7 which yields the desired analytical signal, besides 
depending on reaction 5, that feeds it, is also governed by diffusion of ferrocene 
through the immobilization layer towards the carbon electrode. A schematic 
diagram of a test strip is shown in Figure 2. 
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Figure 2: Schematic representation of a blood glucose test strip 
 
 
 
1.5 In vivo glucose sensors  
 At the time of writing, there are three commercially available in vivo 
glucose sensors, which make use of different technologies (i) Minimed – 
Medtronic System (MMS), (ii) Glucowatch and (iii) Glucoday system [45, 46]. 
However, only MMS will be reviewed as it is more widely used by clinicians. The 
sensor is based on the long – established technology of GOx immobilized at a 
positively charged base electrode, with electrochemical detection of hydrogen 
peroxide production; 
 Glucose + O2 + GOx → H2O2 + gluconic acid  (8) 
 H2O2 → O2 + 2e-       (9) 
H2O2 is detected at 700mV vs SCE. Because the sensor is implanted in the 
subcutaneous tissue, it measures interstitial fluid glucose concentrations, which 
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are similar to blood glucose levels in the steady state but lag behind when 
glycaemia change rapidly, for example after a meal. The magnitude of this lag 
has been variously recorded in numerous studies with needle type enzyme 
electrodes (Table 1). Aside from the lag, two other major problems with MMS are 
unpredictable drift and impaired responses in vivo, which necessitate repeated 
calibration against finger-prick capillary blood glucose concentrations. As in the 
case of MMS, the calibration was performed four times daily. There has been 
considerable speculation as to the reason for lowered and drifting responses of 
sensors implanted in subcutaneous tissue, including protein and cell coating, low 
and varying pO2 or a wound response. The fact that the sensor sensitivity 
remains low after implantation and recovers after repeated washing indicates a 
reversible accumulation of unknown substance on the sensor, rather than tissue 
– related phenomena. In a recent study, MMS profiles were compared to finger – 
prick blood glucose self – monitoring. There were many times when episodes of 
hyperglycemia or hypoglycemia in these patients were missed by intermittent 
testing but detected by continuous sensing. This particularly applied to 
postprandial hyperglycemia and nocturnal hypoglycemia, though the mean and 
oscillations in blood glucose concentrations were about equally assessed by 
MMS and intermittent testing. The accuracy of MMS using the much – used (and 
much criticized) Clarke grid error is apparently good, with about 90% of non – 
calibration paired blood and sensor values falling in the clinically acceptable 
zones. However, in clinical practice important disagreements between sensor 
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and reference blood glucose are not uncommon. This has been reported in the 
past [45, 46].  
 
1.6 Wireless sensing 
In the early 1990s, a two – way voltammetry system based on a wireless 
interconnection via infrared (IR) transmission between the laboratory animal and 
measuring devices was proposed [47 – 50]. The ramp was then sent to the 
working electrode via IR (one way). The consequent oxidation signal was sent 
back yet again via IR to the analyzing system (second way). In vivo recording of 
voltammetric recordings of ascorbic acid obtained by conventional system and IR 
method were well defined and almost identical in shape. Other in vivo 
experiments revealed that the IR could allow the simultaneous recordings of 
neuronal activity. However, dangerous variations of tension at the level of 
working electrode due to occasional, random interruption of the first way IR 
channel appeared to be one of the major problems. In addition, another major 
downside of employing such techniques could be incapability of controlling the 
mobile unit by the fixed station. This is because it operates over short range 
distances and at only medium range bandwith.  
The use of biosensors on awake animals and free of cable tethers i.e. 
wireless transmission would be significant in measuring analyte in physiological 
fluid. Recent advances in wireless networking have opened up new opportunities 
in a variety of applications [51] including healthcare systems [52, 53]. The advent 
of Bluetooth allowed seamless interconnectivity between the animal laboratory 
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and the measuring equipment [51]. Bluetooth system does not require the 
laboratory animal to be confined to the measuring equipment. It also allows the 
animal to move around freely within a specific distance from the measuring 
equipment. Although susceptible to minimal noise interference, the data 
transmission was reliable at 99.9% [54, 55]. The uniqueness of wireless 
communications systems is that it enables ad hoc networking among devices 
without the need for infrastructure such as base stations or access points.  
In developing remote sensing for an amperometric microsensor, a fast 
data acquisition from low amplitude signals exposed to noise artifacts is an 
essential. Although recent developments in digital telemetry hold great promise, it 
is only data rate limiting and its practical application is questionable [55]. 
Besides, an onboard microprocessor is needed for digitizing the analog signals 
obtained from the sensor. The capacity of such a microprocessor in performing 
several tasks simultaneously is doubtful [55, 69 – 71]. Also, measurements 
obtained using remote sensing should be free of electrical interference as 
conventional measurements are, normally, performed without a Faraday cage. 
 
1.7 Objective 
The aim of this study is to monitor subcutaneous and brain striatum 
glucose level in a diabetic and hyperglycemia rat employing “cableless” 
amperometric glucose microsensor. The first part of this study is to fabricate 
glucose microsensors for subcutaneous and brain striatum monitoring. The 
fabricated microsensor is then dipped in rat’s serum (“preconditioned” 
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microsensor) and its performance is compared with the microsensor without 
dipping in the rat’s serum (“clean” microsensor). The “preconditioned” 
microsensor is used for subcutaneous glucose monitoring while the “clean” 
microsensor is used for brain striatum glucose monitoring. The second part of the 
study is to implant the microsensors both subcutaneously and in the brain 
striatum. For subcutaneous glucose studies, hematological aspect on each group 
of rats after the implantation for both types of microsensors are also examined 
and compared. The third part of this study is to establish the viability of the 
remote sensing of amperometric signals from a glucose microsensor. The final 
part involves wireless transmission of subcutaneous and brain striatum glucose 
level. The amperometric current produced from the GOx – glucose reaction is 
transmitted to the home – base unit in a personal computer. Comparisons of 
conventional wired system and glucometer with wireless measurement are also 
made. Taken together, the results obtained establish the proof of wireless 
transmission of amperometry at a glucose microsensor.  
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2.0 Methodology 
 
 
2.1 Materials 
 
The 4-vinylpyridine (4VP) monomer (~96%), mercury (Hg, RdH 10008) 
(99.99%) and tetramethylammonium chloride, (TMAC), were from Fluka 
Chemika, Switzerland and used without further purification. Acetonitrile (MeCN) 
from Romil Chemicals, England; Araldite® epoxy resin from Ciba Geigy, 
Switzerland; Triton® X-100, i.e. polyethylene glycol tert-octylphenyl ether (PEG), 
10% (w/v) and glucose oxidase (GOx) from Asperigillus niger (EC 1.1.3.4, 
catalogue no. 646 431, grade II lyophilised, 100,000 i.u.), obtained from 
Boehringer Mannheim GmbH, Germany were used as received. Bovine serum 
albumin (Fraction V, 98 – 99% albumin), ethyl carbamate, bovine serum, β-D-
glucose, glutaraldehyde and mineral oil were obtained from Sigma Chemicals, 
USA and were used as received. Oxygen-free nitrogen (OFN) was obtained from 
Nissan-IOI, Malaysia. A stock solution of Nafion® (0.5 % w/v) was prepared in 
methanol. Nafion® (5 %w/v) (equivalent mass, 1100 g) in a mixture of low 
molecular weight alcohols and 10 % water was obtained from Aldrich 
(Milwaukee, WI, USA). The composite graphite powder from pencil lead 2B, Mars 
Lumograph 100, was from Staedtler, Germany. All other reagents were of the 
highest grade available and were used as received. 
Bovine serum was first diluted to 80% in phosphate – buffered saline 
(PBS) solution at pH 7.4 prior use. The stock solution of β-D-glucose was also 
prepared in PBS and allowed to mutarotate and left overnight at 4°C before use. 
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This was to establish equilibrium concentrations between α and β anomers. The 
glucose concentrations were reported as total glucose concentrations. The 
phosphate buffered saline (PBS) solution was prepared, daily, by dissolving 
2.754 g of NaCl, 2.081 g of KH2PO4 and 0.477 g of NaOH in 1000 mL of distilled 
water and then pH adjusted to 7.4 with 0.1 M NaOH. Pure water from a Milli-Q 
Plus of Millipore Corp., USA was used for preparation of all aqueous solutions. 
 
2.2 Instrumentation 
 
Most electrochemical measurements and analysis were done using either 
the Potentiostat/Galvanostat (Model 273A, Princeton Applied Research, USA) 
controlled by an IBM PS/2 model 480 PC or Autoranging Microvolt DMM (Model 
197A, Keithley Ins., Cleveland, Ohio, USA). The pH measurement was obtained 
using benchtop pH/ISE meter (model 720A Orion, Boston, USA). Teflon coated 
antimagnetic stainless steel tweezers style #4 (110 mm) and style #3 (120 mm) 
of Sigma Chemicals, St. Louis, USA, was used in the preparation of 
microelectrode. Magnification of microelectrode was seen under a 
stereomicroscope (model SMZ – 2T, Nikon, Japan) and photos were taken with 
an attached camera (model F – 601, Nikon, Japan). The micropippete puller (PB 
– 7) and micropippete grinder (EG – 4) was from Narishige, Japan. The rat’s 
blood glucose level was also determined using glucometer (Accu – Chek® 
Advantage II, with test strips and complete meter, Roche Diagnostics, GmbH, 
Mannheim, Germany). 
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2.3 Microsensors Fabrication 
 
The carbon fiber (8 µm in diameter, 6.4 mm long,) was from Lot # 20590, 
Johnson Matthey Electronics, (MA, USA) was inserted into the glass capillary (1 
x 90 mm GD – 1, Narishige, Japan) using tweezers and was then pulled by a 
micropipette puller ((PB – 7, Narishige, Japan) with maximum weight. The 
protruding carbon fiber was trimmed so that the remaining of the fiber was inside 
the glass capillary. The microelectrodes were then polished at an angle of 45° on 
the micropipette grinder (EG – 4, Narishige, Japan) on an extra – fine diamond 
abrasive plate to produce elliptical carbon disk. Electrical contact was established 
by filling the capillary with mercury (0.5 mL) and then with composite graphite 
paste. Preparation of the composite graphite paste was mentioned elsewhere [56 
– 58]. A copper wire was then inserted into the paste. The upper part of the 
capillary was finally sealed with Araldite® epoxy resin. The microelectrode was 
left sitting at room temperature overnight and was then cured at 70°C for two 
days. It was then washed with acetone, later rinsed with pure water, and finally 
dried in a cold air stream prior to polymer deposition. 
The preparation of P4VP from 4VP was described elsewhere [56 – 58]. 
Briefly, the electrochemical cell was, initially, purged with oxygen – free – 
nitrogen (OFN) gas for 10 minutes. Later P4VP film was anodically 
electrodeposited from the 4VP solution onto the carbon fiber electrode at 
potential from -0.4 V to +0.6 V vs Ag/AgCl and at scan rates of 50 mVs-1, 
respectively with supporting electrolyte either TMAC or TBAP. The pH of the 
solution ranges from 2.9 to 3.5 adjusted by dropwise addition of 0.1M acetic acid 
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or 0.1M NaOH. Upon completion of deposition time, the microelectrode was 
remove carefully and washed with a mixture of acetonitrile and water. The P4VP 
– modified electrode was left to dry under reduced pressure for 30 minutes. The 
GOx was then immobilized onto the polymer modified microelectrodes by 
immersing the microelectrode in 2.0 mL of PBS solution containing 200 i.u.mL-
1GOx and glutaraldehyde for a period of 30 min. The dropwise addition of 10µL 
of stock Nafion® solution was applied onto the GOX/P4VP electrode. The 
resulting microelectrode was allowed to dry under reduced pressure for 5 
minutes. The final assembly of Nafion® - coated GOX/P4VP microelectrode was 
washed, conditioned in PBS and kept at 4°C in the refrigerator for future use. The 
later was referred as a “clean” microelectrode. To minimize inflammatory skin 
reaction, the microsensor was dipped in the rat’s serum for 3 days and was 
referred as the “preconditioned” microelectrode. During this period, the 
amperometric responses of the microsensor towards 10 mM glucose in PBS 
solution at pH 7.0 were evaluated for every 12 h. Prior to dipping, blood samples 
were collected from the rat’s tail and enough amount of heparin was added to 
eradicate coagulation before being were centrifuged at 500 r.p.m. As a result, a 
process similar to membrane biofouling and fibrous encapsulation started even 
before implantation. The so called “passivation” layer was to further eradicate the 
process of membrane biofouling and fibrous encapsulation upon microsensor 
implantation. “Preconditioned” microsensors, after dipping in rat’s serum for 72 
hours were then used for further investigation. The amperometric responses 
towards increasing glucose concentration for both “clean” and “preconditioned” 
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microsensors were investigated at Eapp = +0.23 V vs Ag/AgCl. “Preconditioned” 
microsensor will only be used on subcutaneous glucose monitoring while for 
brain striatum glucose monitoring, “clean” microsensor will be used.§ 
The pseudo Ag/AgCl reference electrode was prepared from a silver wire 
(0.01 mm o.d. 10 cm length). The electrode was dipped in a stirred 0.1 M HCl 
and a current of 0.4 mA cm-2 was passed for a period of 60 min until the silver 
wire was coated with AgCl. The final assembly was then rinsed using pure water. 
A potential of 50 mV was produced when the resulting pseudo Ag/AgCl reference 
electrode was scanned in 0.1 M NaCl at 37°C vs Ag/AgCl (3 M KCl). The 
reference electrode was then sealed to the glass capillary.  
 
 
 
 
2.4 Subcutaneous glucose measurements 
 
Healthy male Sprague – Dawley rats (n=15; 350±50g) were anaesthetized by 
injection of chlorolase/urethane (ethyl carbamate, 1500 mg kg-1, i.p.). Injection of 
anesthesia tends to lower the rat’s body temperature. Thus, a light beam from a 
tungsten lamp (120 W) was used to keep the body temperature within the range 
of 35 - 37°C. The rat’s body oxygen level was maintained by continuously 
supplying of O2 – air. The “clean” microelectrode and the reference electrode 
were implanted without any incision subcutaneously into the dorsal region 
whereas the “preconditioned” micrelectrode and the reference electrode were 
implanted at the back of the neck of the rat. The sensors were then connected to 
                                                 
§ The term “stain” in reference [35] was replaced by “preconditioned” for this thesis 
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Autoranging Microvolt DMM. The measurements were made at an applied 
constant potential of 0.23 V vs Ag/AgCl. The sensors were calibrated before and 
after the in vivo experiment. The rat’s blood sugar level was increased by 
injecting glucose (10 mM glucose min-1 kg-1). In order to check the blood sugar 
level, blood samples were taken at a regular interval in the ear vein (vena 
auricularis posterior). Calibration curve was constructed prior to implantation of 
the microsensor by measuring the amperometric current of prepared glucose 
standard solutions [28, 31]. The one-point calibration procedure was performed a 
posteriori by taking into account the capillary blood glucose concentration 
determined immediately before microsensors implantation infusion, whatever 
their level, and the concomitant sensor output. This procedure was performed 
either once per day (before before sensors implantation, the value of glycemia 
and sensor output being those used in the two-point calibration procedure), twice 
per day or three times per day.  
Capillary blood glucose concentration was determined using glucometer. If 
blood glucose was lower than 5 mM, the rat was given glucose infusion (10 mM 
glucose min-1 kg-1). If blood glucose was higher than 5mM, the implanted sensors 
were disconnected from the measuring devices until the capillary glucose had 
fallen to a stable lower level. A second capillary blood glucose measurement was 
then performed. The two sets of values of capillary blood glucose concentration 
and concomitant sensor output were used to calibrate the sensor. For the other 
days of the trial, the procedure was repeated a posteriori by taking into account 
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the capillary blood glucose concentration observed immediately before glucose 
infusion.  
The output from the sensor was obtained as the experiments proceeded. 
Between measurements (day interval), the microsensor was electrically 
disconnected from the rat, which was not anaesthetized during this period. At the 
end of the course, blood samples were taken from the dorsal region and the back 
of the neck of the rat, i.e. sites implanted with “clean” microsensor and 
“preconditioned” microsensor for hematology examinations [59, 60]. For each rat 
anaesthetized for in – vivo measurement, a new pair of “clean” and 
“preconditioned” microsensor was used. All experiments involving rats have been 
conducted according to approved ethical guidelines [61].  
 
2.5 Brain glucose measurements 
 
 Diabetes was induced in an 285 ± 5 g adult male Sprague – Dawley rat, 
ten days before study, by injecting intravenously STZ (50 mg kg-1 body weight in 
200 mL citrate buffer, pH 4.3) in the penis vein. Four days after STZ infusion, the 
rats received daily injections of protamine zinc insulin at a dosage sufficient 
enough to maintain body weight but insufficient to prevent chronic 
hyperglycemia. The control non – diabetic rats received either saline infusion 
(euglycemia, n = 5) or a variable rate of glucose infusion (20mM glucose min-1 
kg-1 each time) to raise and maintain plasma glucose at diabetic level. 
Chronically hyperglycemic rats received a variable glucose infusion to maintain 
them at their morning glucose level in the range of 22 - 24 mmol L-1 (n = 5). In  
 
